MiR-150 |
Bone marrow |
MDS with del(5q) |
Upregulated |
Role in erythropoiesis, megakaryopoiesis |
MYB, BC200 |
Potential therapeutic target |
(34) |
MiR-125b |
Bone marrow |
t(2;11)(p21;q23) |
Upregulated |
Block the myelomonocytic differentiation |
|
Potential therapeutic target |
(64) |
MiR-194 |
Bone marrow |
Trisomy 1 |
Upregulated |
Apoptosis |
p53 |
Prognostic marker |
(4) |
MiR-595 |
Bone marrow |
Chromosome 7 abnormalities |
Downregulated |
Cellular proliferation, apoptosis, and defective ribosomal biogenesis |
RPL27A |
Potential therapeutic target |
(65) |
miR-449a, miR-300, miR-210, miR-874, miR-589, miR-451 miR-223, miR-128b, miR-342 |
Bone marrow |
MDS with del(5q) |
Downregulated |
|
|
Diagnostic markers |
(66, 67) |
miR-196b, miR-451, miR-98, miR-34a, miR-10a miR-10b, miR-126, miR-99b miR-130a, miR-199a, miR-125a, miR-125b |
Bone marrow |
MDS with del(5q) |
Upregulated |
|
|
Diagnostic markers |
(66, 67) |